Increasingly, JHU-083, a glutamine antagonist was found to alleviate AD pathogenesis and cognitive disorder induced by excess microglial LPS-induced glutaminase (GLS) in APOE 4 knock-in mice (73). This evidence concerns the gene GLS and Alzheimer disease.